Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1008479

registered interest
date	16/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to make flash glucose monitoring technology available to all patients with diabetes across clinical commissioning groups.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	192108
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192109 192110 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

1008480

registered interest
date	16/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential savings to the NHS of making flash glucose monitoring technology available to all patients with diabetes across NHS clinical commissioning groups.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	192109
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192108 192110 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

1008481

registered interest
date	16/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations he has received from (a) the public and (b) charities on the benefits of making flash glucose monitoring technology available to all patients with diabetes.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	192110
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192108 192109 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

937772

registered interest
date	10/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has plans to authorise a national clinical audit of ovarian cancer; and if he will make a statement.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	162542
answer	answer is ministerial correction date of answer 17/07/2018 answer text <p>Public Health England (PHE) has been funded by cancer charities to pilot and assess the feasibility of an ovarian cancer audit, this pilot will take place over the next two years.</p><p> </p><p>Since early diagnosis increases survival outcomes, NHS England is working to diagnose cancer earlier and faster. This is particularly important for cancers like ovarian, where early diagnosis makes a huge difference in survival. We are developing new models of care and pathways that will transform services by speeding up diagnosis. This includes the commitment to roll out a new Faster Diagnosis Standard by 2020 to ensure that patients referred for an investigation with a suspicion of cancer are diagnosed or have cancer ruled out within 28 days.</p><p> </p><p>NHS England has also committed more than £200 million in cancer services between 2017 and 2019, to accelerate diagnosis, improve survival and enhance quality of life.</p><p> </p><p>NHS England is introducing Rapid Diagnostic and Assessment Centres which will operate as one-stop shops to reduce time-to diagnosis and time-to-first treatment. This is a real step change in the way people with unclear symptoms are identified, diagnosed and treated. General practitioners can refer patients suffering from vague symptoms.</p><p> </p><p>NHS England is also delivering the largest single upgrade in National Health Service cancer treatment for the last 15 years. The £130 million radiotherapy modernisation programme is upgrading and replacing radiotherapy equipment in hospitals across England. Through this programme, patients will have access to the most modern, innovative radiotherapy techniques to create better health outcomes and improve patient experience.</p><p> </p><p>The Department is also closely working with PHE to develop an approach to raise awareness of generic symptoms that can indicate a wider number of cancers, including ovarian cancer, and the need to visit the doctor promptly with these symptoms.</p><p> </p><p>PHE also ran a regional pilot ovarian campaign in the North West of England from 10 February to 16 March 2014. The campaign’s key message was ‘Feeling bloated, most days, for three weeks or more could be a sign of ovarian cancer. Tell your doctor’.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 162543 162544 question first answered 17/07/2018 15:05:38 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

937774

registered interest
date	10/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase ovarian cancer survival rates.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	162543
answer	answer is ministerial correction date of answer 17/07/2018 answer text <p>Public Health England (PHE) has been funded by cancer charities to pilot and assess the feasibility of an ovarian cancer audit, this pilot will take place over the next two years.</p><p> </p><p>Since early diagnosis increases survival outcomes, NHS England is working to diagnose cancer earlier and faster. This is particularly important for cancers like ovarian, where early diagnosis makes a huge difference in survival. We are developing new models of care and pathways that will transform services by speeding up diagnosis. This includes the commitment to roll out a new Faster Diagnosis Standard by 2020 to ensure that patients referred for an investigation with a suspicion of cancer are diagnosed or have cancer ruled out within 28 days.</p><p> </p><p>NHS England has also committed more than £200 million in cancer services between 2017 and 2019, to accelerate diagnosis, improve survival and enhance quality of life.</p><p> </p><p>NHS England is introducing Rapid Diagnostic and Assessment Centres which will operate as one-stop shops to reduce time-to diagnosis and time-to-first treatment. This is a real step change in the way people with unclear symptoms are identified, diagnosed and treated. General practitioners can refer patients suffering from vague symptoms.</p><p> </p><p>NHS England is also delivering the largest single upgrade in National Health Service cancer treatment for the last 15 years. The £130 million radiotherapy modernisation programme is upgrading and replacing radiotherapy equipment in hospitals across England. Through this programme, patients will have access to the most modern, innovative radiotherapy techniques to create better health outcomes and improve patient experience.</p><p> </p><p>The Department is also closely working with PHE to develop an approach to raise awareness of generic symptoms that can indicate a wider number of cancers, including ovarian cancer, and the need to visit the doctor promptly with these symptoms.</p><p> </p><p>PHE also ran a regional pilot ovarian campaign in the North West of England from 10 February to 16 March 2014. The campaign’s key message was ‘Feeling bloated, most days, for three weeks or more could be a sign of ovarian cancer. Tell your doctor’.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 162542 162544 question first answered 17/07/2018 15:05:38 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

937775

registered interest
date	10/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the level of early diagnosis of ovarian cancer.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	162544
answer	answer is ministerial correction date of answer 17/07/2018 answer text <p>Public Health England (PHE) has been funded by cancer charities to pilot and assess the feasibility of an ovarian cancer audit, this pilot will take place over the next two years.</p><p> </p><p>Since early diagnosis increases survival outcomes, NHS England is working to diagnose cancer earlier and faster. This is particularly important for cancers like ovarian, where early diagnosis makes a huge difference in survival. We are developing new models of care and pathways that will transform services by speeding up diagnosis. This includes the commitment to roll out a new Faster Diagnosis Standard by 2020 to ensure that patients referred for an investigation with a suspicion of cancer are diagnosed or have cancer ruled out within 28 days.</p><p> </p><p>NHS England has also committed more than £200 million in cancer services between 2017 and 2019, to accelerate diagnosis, improve survival and enhance quality of life.</p><p> </p><p>NHS England is introducing Rapid Diagnostic and Assessment Centres which will operate as one-stop shops to reduce time-to diagnosis and time-to-first treatment. This is a real step change in the way people with unclear symptoms are identified, diagnosed and treated. General practitioners can refer patients suffering from vague symptoms.</p><p> </p><p>NHS England is also delivering the largest single upgrade in National Health Service cancer treatment for the last 15 years. The £130 million radiotherapy modernisation programme is upgrading and replacing radiotherapy equipment in hospitals across England. Through this programme, patients will have access to the most modern, innovative radiotherapy techniques to create better health outcomes and improve patient experience.</p><p> </p><p>The Department is also closely working with PHE to develop an approach to raise awareness of generic symptoms that can indicate a wider number of cancers, including ovarian cancer, and the need to visit the doctor promptly with these symptoms.</p><p> </p><p>PHE also ran a regional pilot ovarian campaign in the North West of England from 10 February to 16 March 2014. The campaign’s key message was ‘Feeling bloated, most days, for three weeks or more could be a sign of ovarian cancer. Tell your doctor’.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 162542 162543 question first answered 17/07/2018 15:05:38 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

937860

registered interest
date	10/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Data Protection
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the costs incurred to the NHS from third-parties making subject access requests under General Data Protection Regulation instead of using the Access to Medical Reports Act 1988.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	162545
answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>No such assessment has been made. The General Data Protection Regulation (GDPR) is not the correct route for such requests. The right of access under GDPR confers more personal information than is needed or is justified for insurance underwriting. Accordingly, insurance companies should instead use the established mechanism of the Access to Medical Reports Act 1988 (AMRA) to obtain summary medical reports from general practitioner (GPs). The AMRA allows the GP to charge a reasonable fee to cover the cost of copying the report.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 18/07/2018 16:37:24 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4079 label Biography information for Julian Sturdy

935012

registered interest
date	05/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Parking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the feasibility of abolishing hospital parking charges in the last three months; and if he will make a statement.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	161148
answer	answer is ministerial correction date of answer 12/07/2018 answer text <p>The Department keeps the issue of car parking charges under review following its 2015 guidance on National Health Service patient, visitor and staff car parking which is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/nhs-patient-visitor-and-staff-car-parking-principles/nhs-patient-visitor-and-staff-car-parking-principles" target="_blank">https://www.gov.uk/government/publications/nhs-patient-visitor-and-staff-car-parking-principles/nhs-patient-visitor-and-staff-car-parking-principles</a></p><p> </p><p>Income generated from parking charges is used to pay the costs of providing the parking e.g. maintenance, security and lighting, and avoid funds being taken from budgets for healthcare services. If any excess is generated, it is used to fund clinical services.</p><p> </p><p>NHS trusts make decisions locally about the provision of car parking to patients, visitors and staff, and are provided guidance by the Department in published car parking principles. The principles provide a sufficient mandate for trusts to take a responsible approach to charging, including recommendations to charge on exit and providing reduced costs.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay grouped question UIN 161149 question first answered 12/07/2018 13:47:04 answering member 4095 label Biography information for Steve Barclay
tabling member	4079 label Biography information for Julian Sturdy

935013

registered interest
date	05/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Parking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how the proceeds from hospital car parking charges are used.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	161149
answer	answer is ministerial correction date of answer 12/07/2018 answer text <p>The Department keeps the issue of car parking charges under review following its 2015 guidance on National Health Service patient, visitor and staff car parking which is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/nhs-patient-visitor-and-staff-car-parking-principles/nhs-patient-visitor-and-staff-car-parking-principles" target="_blank">https://www.gov.uk/government/publications/nhs-patient-visitor-and-staff-car-parking-principles/nhs-patient-visitor-and-staff-car-parking-principles</a></p><p> </p><p>Income generated from parking charges is used to pay the costs of providing the parking e.g. maintenance, security and lighting, and avoid funds being taken from budgets for healthcare services. If any excess is generated, it is used to fund clinical services.</p><p> </p><p>NHS trusts make decisions locally about the provision of car parking to patients, visitors and staff, and are provided guidance by the Department in published car parking principles. The principles provide a sufficient mandate for trusts to take a responsible approach to charging, including recommendations to charge on exit and providing reduced costs.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay grouped question UIN 161148 question first answered 12/07/2018 13:47:03 answering member 4095 label Biography information for Steve Barclay
tabling member	4079 label Biography information for Julian Sturdy

922333

registered interest
date	12/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Packaging
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increased uniformity of medication packaging across manufacturers to enable the efficient identification of all medicines.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	152755
answer	answer is ministerial correction date of answer 20/06/2018 answer text <p>The Government has produced guidance in conjunction with experts in clinical practice and in the field of design for those who produce medicines packaging which recommends the judicious use of colour to ensure medicines are well differentiated to reduce the likelihood of error. In developing the principles within this guidance, the views of healthcare professionals and patients have been considered.</p><p> </p><p>While there are detailed legal requirements with respect to the content of the information provided on the packaging there are no provisions with respect to colour and design of the packaging when presented to the market place.</p><p> </p><p>Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing. Where specific safety issues have been identified, for example with medicines containing warfarin, particular colours both for the tablets and the packaging have been adopted as an industry standard.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 152756 152757 question first answered 20/06/2018 16:03:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4079 label Biography information for Julian Sturdy